← All companies

AMIX

Autonomix Medical, Inc.

AMIX Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$3.65

+0.06 +1.67%

Key statistics

from XBRL data in SEC filings

Market cap

$41.6M

Revenue (TTM)

$0.00

Net income (TTM)

-$16.7M

EPS (TTM)

$-2.32

P/E ratio

—

Dividend yield

—

Free cash flow

-$12.3M

Cash

$7.00M

Total assets

$7.60M

Gross margin

—

52-week range

$2.44 – $32.55

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 28, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 15, 2026 8-K Other events Jul 10, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jun 24, 2026 10-K/A Fiscal year ended 2026-03-31 Jun 15, 2026 10-K Fiscal year ended 2026-03-31 May 27, 2026 10-Q Quarter ended 2025-12-31 Feb 11, 2026 8-K Delisting notice or listing-rule failure Jan 16, 2026 8-K Regulation FD disclosure Jan 9, 2026 8-K Entered a material agreement; Unregistered sale of equity Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Shareholder vote results Nov 3, 2025 8-K Other events Aug 27, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 26, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 10-K/A Fiscal year ended 2025-03-31 Jul 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 22, 2025 10-K Fiscal year ended 2025-03-31 May 29, 2025 8-K Regulation FD disclosure Apr 30, 2025 8-K Entered a material agreement; Other events Feb 28, 2025 8-K Results of operations (earnings release) Feb 13, 2025 10-Q Quarter ended 2024-12-31 Feb 13, 2025 8-K Regulation FD disclosure Jan 22, 2025 8-K Entered a material agreement; Other events Nov 25, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Other events Nov 4, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events Oct 28, 2024 8-K Shareholder vote results Oct 17, 2024 8-K Delisting notice or listing-rule failure Sep 20, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 10-K/A Fiscal year ended 2024-03-31 Jul 26, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 15, 2024 8-K Director or officer change Jun 21, 2024 8-K Regulation FD disclosure Jun 18, 2024 8-K Unregistered sale of equity; Director or officer change; Regulation FD disclosure Jun 17, 2024 10-K Fiscal year ended 2024-03-31 May 31, 2024 8-K Results of operations (earnings release) May 31, 2024 8-K Regulation FD disclosure Mar 4, 2024